Testicular cancer is one of the great success stories of modern oncology, with cure rates that exceed ninety percent even in many advanced cases. Yet behind that headline statistic lies a diagnostic fork in the road that matters enormously for every patient: the tumour may be a seminoma, a relatively uniform and exquisitely radiation-sensitive malignancy, or a non-seminomatous germ cell tumour, a biologically restless entity that demands differe…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.